Developer docs
API playgroundTry for free, no card

Search company profiles

COVVI

Full company profile

uuid000a8k4

Namestring
COVVI
Websiteurl
covvi.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

COVVI is a private UK-based company founded in 2017 and headquartered in Leeds, specializing in the design and distribution of the COVVI hand, an advanced bionic prosthetic. The company serves amputees and limb-different individuals as its primary user base, with a secondary channel through healthcare providers and rehabilitation centers that distribute bionic prosthetics to patients requiring limb replacement. Use cases span upper and lower extremity prosthetics, including myoelectric and microprocessor-controlled devices, addressing restoration of limb function, improved mobility, and enhanced quality of life for individuals with limb loss due to trauma, disease, or congenital conditions.

The COVVI hand is positioned within the intelligent bionic prosthesis segment, where third-party sources cite AI-integrated prosthetic technologies as a key technological driver enabling more intuitive motor control and better user outcomes. The company emphasizes advanced bionic prosthetic solutions providing improved motor control, enhanced dexterity, and better integration with the human body compared to traditional prosthetic options. The upper limbs segment is specifically projected to exhibit substantial growth due to the complexity of restoring fine motor skills, which aligns with COVVI's hand-focused product strategy.

COVVI operates with a lean team of 11-50 employees in a market environment characterized by rapid expansion — the global intelligent bionic prosthesis market is projected to grow from $891 million (2025) to over $7.5 billion (2030), with adjacent markets (AI-powered prosthetics at 15.9% CAGR, robotic prosthetics at 9.4% CAGR, and broader artificial limbs at 5.60% CAGR) all showing strong forward momentum. The company operates in a segment challenged by high device costs and limited insurance reimbursement. No publicly disclosed pricing, distribution channels, revenue figures, funding rounds, management team details, patents, certifications, or partnerships are available for COVVI; the company website returns only a verification/loading page with no substantive content, and all available signals derive from third-party market analysis rather than first-party company disclosures.

Short descriptiontext

COVVI designs and distributes the COVVI hand, an advanced bionic prosthetic targeting amputees and limb-different individuals. The Leeds, UK-based private company serves individual patients and healthcare providers within the rapidly growing intelligent bionic prosthesis market.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLeeds, United Kingdom
HQ citystring
Leeds
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
bionic prosthetic hand, robotic prosthetics, upper limb prosthetics, myoelectric prosthesis, artificial limbs
Industry3 codes
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAMAD
Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Bionic Prosthetics
Social media profiles3 records
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

COVVI designs and distributes the COVVI hand, a bionic prosthetic hand intended for amputees and limb-different individuals. The company operates in the upper-limb prosthetics segment of the intelligent bionic prosthesis and robotic prosthetics market, delivering advanced electromechanical prosthetic devices that aim to restore fine motor function.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1COVVI Hand
CategoryUpper Limb Prosthetics
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Leeds-headquartered prosthetics manufacturer with a heritage upper-limb product line including the bebionic-equivalent Steeper hand. Particularly relevant as a fellow Leeds-based prosthetics peer competing for UK clinics.

TypeBroad incumbent
Description

Global prosthetics market leader offering the bebionic and Michelangelo myoelectric hands alongside a full lower-limb and orthopedic portfolio. Competes with COVVI in upper-limb myoelectric systems but at vastly greater scale and distribution.

TypeBroad incumbent
Description

Global prosthetics and orthotics major with a broad upper- and lower-limb portfolio including bionic solutions. Competes with COVVI across the prosthetics channel but as a diversified incumbent rather than a hand specialist.

TypeDirect peer
Description

US-based maker of the Ability Hand, a bionic prosthetic hand with sensor-enabled touch feedback. Direct competitor in the AI/sensor-driven multi-grip hand space targeting upper-limb amputees.

TypeEmerging player
Description

US/China-based neurotechnology company producing the BrainRobotics bionic hand. Comparable AI/EMG-controlled upper-limb prosthetic emerging from a tech rather than traditional medical-device background.

TypeDirect peer
Description

Bristol-based developer of multi-grip bionic arms including the Hero Arm. The closest direct peer to COVVI given comparable product form factor (3D-printed multi-articulating hand), UK origin, and upper-limb amputee target market.

TypeDirect peer
Description

New Zealand-based maker of the TASKA multi-articulating waterproof prosthetic hand. Direct competitor in the bionic hand category with a similar feature focus on dexterity and ruggedization.

TypeDirect peer
Description

US company commercializing the LUKE/DEKA arm, an advanced multi-articulating prosthetic upper limb. Comparable AI-driven bionic upper-limb technology targeting similar patient populations.

TypeDirect peer
Description

Developed the i-LIMB multi-articulating prosthetic hand, the archetype product for COVVI's category. Now integrated into Ottobock but historically a direct competitor in bionic upper-limb prosthetics.

10Vincent Systems
TypeDirect peer
Description

German manufacturer of the Michelangelo and newer Evolution bionic hands. Direct competitor in the same multi-articulating upper-limb category with established European prosthetist distribution.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

COVVI

Bionic Prostheticscovvi.com

COVVI designs and distributes the COVVI hand, an advanced bionic prosthetic targeting amputees and limb-different individuals. The Leeds, UK-based private company serves individual patients and healthcare providers within the rapidly growing intelligent bionic prosthesis market.

What COVVI does

COVVI is a private UK-based company founded in 2017 and headquartered in Leeds, specializing in the design and distribution of the COVVI hand, an advanced bionic prosthetic. The company serves amputees and limb-different individuals as its primary user base, with a secondary channel through healthcare providers and rehabilitation centers that distribute bionic prosthetics to patients requiring limb replacement. Use cases span upper and lower extremity prosthetics, including myoelectric and microprocessor-controlled devices, addressing restoration of limb function, improved mobility, and enhanced quality of life for individuals with limb loss due to trauma, disease, or congenital conditions.

The COVVI hand is positioned within the intelligent bionic prosthesis segment, where third-party sources cite AI-integrated prosthetic technologies as a key technological driver enabling more intuitive motor control and better user outcomes. The company emphasizes advanced bionic prosthetic solutions providing improved motor control, enhanced dexterity, and better integration with the human body compared to traditional prosthetic options. The upper limbs segment is specifically projected to exhibit substantial growth due to the complexity of restoring fine motor skills, which aligns with COVVI's hand-focused product strategy.

COVVI operates with a lean team of 11-50 employees in a market environment characterized by rapid expansion — the global intelligent bionic prosthesis market is projected to grow from $891 million (2025) to over $7.5 billion (2030), with adjacent markets (AI-powered prosthetics at 15.9% CAGR, robotic prosthetics at 9.4% CAGR, and broader artificial limbs at 5.60% CAGR) all showing strong forward momentum. The company operates in a segment challenged by high device costs and limited insurance reimbursement. No publicly disclosed pricing, distribution channels, revenue figures, funding rounds, management team details, patents, certifications, or partnerships are available for COVVI; the company website returns only a verification/loading page with no substantive content, and all available signals derive from third-party market analysis rather than first-party company disclosures.

COVVI firmographics

Firmographics
Name
COVVI
Website
https://covvi.com
Company type
Private
Founded year
2017
Headcount range
11–50 employees
Short description
COVVI designs and distributes the COVVI hand, an advanced bionic prosthetic targeting amputees and limb-different individuals. The Leeds, UK-based private company serves individual patients and healthcare providers within the rapidly growing intelligent bionic prosthesis market.
Ownership category
akta.pro rank

COVVI industry classification

Industry
Product category
Bionic Prosthetics
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAMAD
Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Bionic prosthetic hand
  • Robotic prosthetics
  • Upper limb prosthetics
  • Myoelectric prosthesis
  • Artificial limbs

Where COVVI is headquartered

Location

Headquarters

HQ city
Leeds
HQ country
United Kingdom
HQ region
Europe

Markets served

COVVI business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

COVVI product offering

Product offering

Core offering

COVVI designs and distributes the COVVI hand, a bionic prosthetic hand intended for amputees and limb-different individuals. The company operates in the upper-limb prosthetics segment of the intelligent bionic prosthesis and robotic prosthetics market, delivering advanced electromechanical prosthetic devices that aim to restore fine motor function.

Differentiator

Problem solved

Functional benefit

Products and services

  • COVVI Hand

Companies that use COVVI

Customer profile

Segments2 records

Ideal customer profiles2 records

COVVI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

COVVI partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves1 record

Expansion highlights1 record

COVVI competitors and assessment

Company assessment

Direct peers

  • Steeper Group: Leeds-headquartered prosthetics manufacturer with a heritage upper-limb product line including the bebionic-equivalent Steeper hand. Particularly relevant as a fellow Leeds-based prosthetics peer competing for UK clinics.
  • Psyonic: US-based maker of the Ability Hand, a bionic prosthetic hand with sensor-enabled touch feedback. Direct competitor in the AI/sensor-driven multi-grip hand space targeting upper-limb amputees.
  • Open Bionics: Bristol-based developer of multi-grip bionic arms including the Hero Arm. The closest direct peer to COVVI given comparable product form factor (3D-printed multi-articulating hand), UK origin, and upper-limb amputee target market.
  • TASKA Prosthetics: New Zealand-based maker of the TASKA multi-articulating waterproof prosthetic hand. Direct competitor in the bionic hand category with a similar feature focus on dexterity and ruggedization.
  • Mobius Bionics: US company commercializing the LUKE/DEKA arm, an advanced multi-articulating prosthetic upper limb. Comparable AI-driven bionic upper-limb technology targeting similar patient populations.
  • Touch Bionics (now part of Ottobock): Developed the i-LIMB multi-articulating prosthetic hand, the archetype product for COVVI's category. Now integrated into Ottobock but historically a direct competitor in bionic upper-limb prosthetics.
  • Vincent Systems: German manufacturer of the Michelangelo and newer Evolution bionic hands. Direct competitor in the same multi-articulating upper-limb category with established European prosthetist distribution.

Broad incumbents

  • Ottobock: Global prosthetics market leader offering the bebionic and Michelangelo myoelectric hands alongside a full lower-limb and orthopedic portfolio. Competes with COVVI in upper-limb myoelectric systems but at vastly greater scale and distribution.
  • Össur: Global prosthetics and orthotics major with a broad upper- and lower-limb portfolio including bionic solutions. Competes with COVVI across the prosthetics channel but as a diversified incumbent rather than a hand specialist.

Emerging players

  • BrainCo: US/China-based neurotechnology company producing the BrainRobotics bionic hand. Comparable AI/EMG-controlled upper-limb prosthetic emerging from a tech rather than traditional medical-device background.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

COVVI social profiles

Digital presence

COVVI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

COVVI leadership team

Management profile

Number of profiles

COVVI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

COVVI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COVVI

What does COVVI do?

COVVI designs and distributes the COVVI hand, a bionic prosthetic hand intended for amputees and limb-different individuals. The company operates in the upper-limb prosthetics segment of the intelligent bionic prosthesis and robotic prosthetics market, delivering advanced electromechanical prosthetic devices that aim to restore fine motor function.

When was COVVI founded?

COVVI was founded in 2017. It employs 11 to 50 people.

Where is COVVI based?

COVVI is headquartered in Leeds, United Kingdom, in the Europe region.

Who are COVVI's main competitors?

Direct peers on record are Steeper Group, Psyonic, Open Bionics, TASKA Prosthetics, Mobius Bionics, Touch Bionics (now part of Ottobock) and Vincent Systems. Broad incumbents are Ottobock and Össur. BrainCo is listed as an emerging player.

Does COVVI have an API?

No public API is recorded for COVVI.

What industry is COVVI in?

COVVI's product category is Bionic Prosthetics. Its primary akta.pro industry code is HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems), with a secondary code of HLAHAMAD, Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Med-Tech InsightsWinners announced at Medilink Healthcare Business AwardsMedilink North of England Healthcare Business Awards 2026 were held in Sheffield on 30 April, marking 30 years of the association. Winners included Mitotype Precision Labs, JRI Orthopaedics, and others across categories. The event was supported by Equans Sci-Tech and featured a keynote by Professor Shafi Ahmed.Robotics & Automation NewsCovvi unveils ‘futuristic’ robotic hand that ‘pushes new technological boundaries’Covvi unveiled a robotic hand designed for industrial and academic use, built on its prosthetic technology. The hand supports teleoperation and integrates with robotic arms, and is ISO 9001 and ISO 13485 certified. Covvi aims to transform industrial and learning settings globally.Business & FinancialCovvi Unveils 'Futuristic' Robotic Hand That 'Pushes New Technological Boundaries'Covvi unveiled a robotic hand on January 20, 2025, designed for industrial and academic use. The multi-articulated hand can be teleoperated and integrated with robotic arms, and the company cites ISO 9001 and ISO 13485 standards for quality.Yorkshire PostHow Leeds-based COVVI is designing and producing a world leading bionic handLeeds-based COVVI designs and produces a bionic hand for amputees and those with congenital limb deficiencies, with paralympic swimmer Jessica Smith as an advocate. The company has become profitable, doubled its production facility, and aims to sell 100 hands monthly within 12-18 months.